According to GlobalData analyst Dr Andrew S Thompson, the deal signals Thermo Fisher’s move away from the IVD space.
Dipylon Medical Expands Access to Clinical Microbiology Equipment for Modern Diagnostic Laboratories
SINGAPORE, SG / ACCESS Newswire / March 7, 2026 / Dipylon Medical, a specialized provider of laboratory and diagnostic technologies, today announced the expansion of its portfolio of clinical ...
Fueled by experimentation and imagination, we set out to grasp nature’s underlying design and purpose. A significant turning point came with decoding the genetic code, which revealed the basic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results